NEWFOUNDLAND
LIVE

Serial Number

79400320

Owner

Newfoundland Diagnostics Ltd

Attorney

Kenneth F. Florek

Filing Date

Jun 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NEWFOUNDLAND Trademark

Serial Number: 79400320 • Registration: 8090435

NEWFOUNDLAND is a trademark filed by Newfoundland Diagnostics Ltd on June 18, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Newfoundland Diagnostics Ltd

3a Station Road

Entity Type: 99

Newfoundland IP Ltd

3a Station Road,

Entity Type: 98

Trademark Details

Filing Date

June 18, 2024

Registration Date

January 6, 2026

Published for Opposition

November 18, 2025

Goods & Services

downloadable and recorded computer software for medical testing; downloadable and recorded computer software applications for mobile devices; electronic publications downloadable, namely, medical brochures

medical testing apparatus and instruments for infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19, blood tests, eye tests, genetic testing; medical apparatus and instruments for infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19, blood tests, eye tests, genetic testing

retail and wholesale store services featuring pharmaceuticals, medical preparations, medical diagnostic reagents and test strips, medical diagnostic and testing preparations to detect and diagnose infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, hiv (human immunodeficiency virus), hpv (human papillomavirus), uti (urinary tract infection), and covid-19, pregnancy testing preparations, diagnostic testing materials for medical use, chemical preparations for testing blood for medical purposes, genetic identity tests comprised of reagents for medical purposes, surgical, medical, and dental apparatus and instruments, medical testing apparatus and instruments, medical apparatus and instruments for infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, hiv (human immunodeficiency virus), hpv (human papillomavirus), uti (urinary tract infection), and covid-19, blood tests, eye tests, genetic testing; marketing, advertising and publicity services; provision of on-line advertising space; operation and management of gift card, discount card and customer loyalty schemes

medical diagnostic reagents and test strips; medical diagnostic and testing preparations to detect and diagnose infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19; pregnancy testing preparations; chemical preparations for testing blood for medical purposes; genetic identity tests comprised of reagents for medical purposes

Medical services; medical laboratory testing and analysis services; medical assessments and screening; medical diagnostic services; medical consultation; medical and health services relating to DNA, genetics and genetic testing; alcohol and drug testing for substance abuse; health risk assessment surveys; mental health screening services; pre-employment medical and health screening testing services; providing information and advice in connection with the aforementioned services.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 6, 2026 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2026 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 1, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 17, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 17, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2025 TROA
REFUSAL PROCESSED BY IB
Jul 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2025 NWOS
CHANGE OF OWNER RECEIVED FROM IB
Jul 26, 2024 CHLD
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 18, 2024 SDRC